AVXL logo

Anavex Life Sciences (AVXL) Operating profit

annual operating profit:

-$52.80M+$2.93M(+5.26%)
September 30, 2024

Summary

  • As of today (July 4, 2025), AVXL annual operating income is -$52.80 million, with the most recent change of +$2.93 million (+5.26%) on September 30, 2024.
  • During the last 3 years, AVXL annual operating profit has fallen by -$10.85 million (-25.87%).
  • AVXL annual operating profit is now -364051.72% below its all-time high of -$14.50 thousand, reached on September 30, 2004.

Performance

AVXL Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVXLincome statement metrics

quarterly operating profit:

-$12.42M+$1.16M(+8.56%)
March 31, 2025

Summary

  • As of today (July 4, 2025), AVXL quarterly operating income is -$12.42 million, with the most recent change of +$1.16 million (+8.56%) on March 31, 2025.
  • Over the past year, AVXL quarterly operating profit has dropped by -$265.00 thousand (-2.18%).
  • AVXL quarterly operating profit is now -302753.66% below its all-time high of -$4100.00, reached on December 31, 2004.

Performance

AVXL quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVXLincome statement metrics

TTM operating profit:

-$54.99M-$265.00K(-0.48%)
March 31, 2025

Summary

  • As of today (July 4, 2025), AVXL TTM operating income is -$54.99 million, with the most recent change of -$265.00 thousand (-0.48%) on March 31, 2025.
  • Over the past year, AVXL TTM operating profit has dropped by -$5.27 million (-10.61%).
  • AVXL TTM operating profit is now -1341046.34% below its all-time high of -$4100.00, reached on December 31, 2004.

Performance

AVXL TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVXLincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

AVXL Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+5.3%-2.2%-10.6%
3 y3 years-25.9%-7.8%-17.4%
5 y5 years-83.3%-61.3%-85.1%

AVXL Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-25.9%+5.3%-9.1%+19.1%-14.7%+4.6%
5 y5-year-83.3%+5.3%-65.4%+19.1%-85.1%+4.6%
alltimeall time<-9999.0%+5.3%<-9999.0%+19.1%<-9999.0%+4.6%

AVXL Operating profit History

DateAnnualQuarterlyTTM
Mar 2025
-
-$12.42M(-8.6%)
-$54.99M(+0.5%)
Dec 2024
-
-$13.58M(-4.8%)
-$54.72M(+4.2%)
Sep 2024
-$52.80M(-5.3%)
-$14.26M(-3.2%)
-$52.52M(+3.2%)
Jun 2024
-
-$14.73M(+21.2%)
-$50.91M(+2.4%)
Mar 2024
-
-$12.15M(+6.8%)
-$49.71M(-2.5%)
Dec 2023
-
-$11.38M(-10.1%)
-$51.00M(-7.2%)
Sep 2023
-$55.73M(+9.3%)
-$12.65M(-6.5%)
-$54.98M(-4.6%)
Jun 2023
-
-$13.53M(+0.7%)
-$57.61M(+1.9%)
Mar 2023
-
-$13.44M(-12.5%)
-$56.54M(+3.5%)
Dec 2022
-
-$15.36M(+0.5%)
-$54.62M(+7.1%)
Sep 2022
-$50.99M(+21.5%)
-$15.28M(+22.7%)
-$50.99M(+6.3%)
Jun 2022
-
-$12.46M(+8.2%)
-$47.95M(+2.4%)
Mar 2022
-
-$11.52M(-1.7%)
-$46.85M(+5.8%)
Dec 2021
-
-$11.72M(-4.3%)
-$44.28M(+5.5%)
Sep 2021
-$41.95M(+35.6%)
-$12.25M(+7.9%)
-$41.95M(+12.8%)
Jun 2021
-
-$11.36M(+27.0%)
-$37.20M(+9.6%)
Mar 2021
-
-$8.94M(-4.8%)
-$33.95M(+3.8%)
Dec 2020
-
-$9.40M(+25.2%)
-$32.71M(+5.7%)
Sep 2020
-$30.94M(+7.4%)
-$7.51M(-7.4%)
-$30.94M(+4.2%)
Jun 2020
-
-$8.11M(+5.3%)
-$29.70M(+3.6%)
Mar 2020
-
-$7.70M(+0.9%)
-$28.67M(-1.3%)
Dec 2019
-
-$7.63M(+21.6%)
-$29.03M(+0.8%)
Sep 2019
-$28.81M(+50.2%)
-$6.27M(-11.3%)
-$28.81M(+1.6%)
Jun 2019
-
-$7.07M(-12.3%)
-$28.35M(+9.8%)
Mar 2019
-
-$8.07M(+9.0%)
-$25.82M(+14.8%)
Dec 2018
-
-$7.40M(+27.3%)
-$22.49M(+17.2%)
Sep 2018
-$19.18M(+23.5%)
-$5.81M(+28.0%)
-$19.18M(+3.4%)
Jun 2018
-
-$4.54M(-4.0%)
-$18.55M(+5.1%)
Mar 2018
-
-$4.73M(+15.7%)
-$17.64M(+6.9%)
Dec 2017
-
-$4.09M(-21.0%)
-$16.50M(+6.2%)
Sep 2017
-$15.54M(+0.6%)
-$5.18M(+42.4%)
-$15.54M(-8.1%)
Jun 2017
-
-$3.64M(+1.2%)
-$16.92M(+9.0%)
Mar 2017
-
-$3.59M(+14.6%)
-$15.53M(+10.2%)
Dec 2016
-
-$3.13M(-52.2%)
-$14.09M(-5.3%)
Sep 2016
-$15.45M(+117.3%)
-$6.56M(+191.9%)
-$14.88M(+21.1%)
Jun 2016
-
-$2.25M(+4.3%)
-$12.29M(+6.3%)
Mar 2016
-
-$2.15M(-45.1%)
-$11.56M(+12.6%)
Dec 2015
-
-$3.92M(-1.1%)
-$10.26M(+44.3%)
Sep 2015
-$7.11M
-$3.97M(+162.2%)
-$7.11M(+88.0%)
Jun 2015
-
-$1.51M(+76.3%)
-$3.78M(+15.7%)
Mar 2015
-
-$858.30K(+11.4%)
-$3.27M(-4.7%)
DateAnnualQuarterlyTTM
Dec 2014
-
-$770.70K(+20.5%)
-$3.43M(+15.5%)
Sep 2014
-$2.97M(+38.9%)
-$639.40K(-36.0%)
-$2.97M(-21.8%)
Jun 2014
-
-$998.80K(-2.2%)
-$3.80M(+29.8%)
Mar 2014
-
-$1.02M(+229.8%)
-$2.93M(+44.0%)
Dec 2013
-
-$309.60K(-78.9%)
-$2.03M(-5.0%)
Sep 2013
-$2.14M(-50.5%)
-$1.47M(+1065.4%)
-$2.14M(+63.1%)
Jun 2013
-
-$126.00K(-0.9%)
-$1.31M(-30.3%)
Mar 2013
-
-$127.10K(-69.4%)
-$1.88M(-26.2%)
Dec 2012
-
-$415.40K(-35.2%)
-$2.55M(-41.0%)
Sep 2012
-$4.32M(-30.1%)
-$641.40K(-7.9%)
-$4.32M(-11.9%)
Jun 2012
-
-$696.30K(-12.4%)
-$4.90M(-16.1%)
Mar 2012
-
-$794.70K(-63.7%)
-$5.84M(-16.5%)
Dec 2011
-
-$2.19M(+78.6%)
-$6.99M(+13.3%)
Sep 2011
-$6.17M(+9.3%)
-$1.22M(-25.1%)
-$6.17M(-10.7%)
Jun 2011
-
-$1.63M(-16.0%)
-$6.91M(+5.0%)
Mar 2011
-
-$1.95M(+42.3%)
-$6.58M(+7.0%)
Dec 2010
-
-$1.37M(-30.4%)
-$6.15M(+8.6%)
Sep 2010
-$5.65M(+19.3%)
-$1.96M(+50.7%)
-$5.66M(+3.0%)
Jun 2010
-
-$1.30M(-14.1%)
-$5.50M(+0.8%)
Mar 2010
-
-$1.52M(+72.4%)
-$5.46M(+15.9%)
Dec 2009
-
-$880.00K(-51.1%)
-$4.71M(-0.5%)
Sep 2009
-$4.73M(-10.2%)
-$1.80M(+43.3%)
-$4.73M(-15.7%)
Jun 2009
-
-$1.26M(+63.2%)
-$5.62M(+4.9%)
Mar 2009
-
-$770.00K(-15.0%)
-$5.36M(+1.9%)
Dec 2008
-
-$905.80K(-66.3%)
-$5.26M(-1.5%)
Sep 2008
-$5.27M(+234.0%)
-$2.69M(+169.9%)
-$5.34M(+40.7%)
Jun 2008
-
-$995.00K(+48.1%)
-$3.79M(+24.2%)
Mar 2008
-
-$671.70K(-32.0%)
-$3.06M(+19.7%)
Dec 2007
-
-$987.50K(-13.4%)
-$2.55M(+61.8%)
Sep 2007
-$1.58M(+6063.7%)
-$1.14M(+346.3%)
-$1.58M(+256.5%)
Jun 2007
-
-$255.60K(+51.4%)
-$442.50K(+129.8%)
Mar 2007
-
-$168.80K(+1272.4%)
-$192.60K(+575.8%)
Dec 2006
-
-$12.30K(+112.1%)
-$28.50K(+11.3%)
Sep 2006
-$25.60K(-72.1%)
-$5800.00(+1.8%)
-$25.60K(-58.6%)
Jun 2006
-
-$5700.00(+21.3%)
-$61.80K(-39.3%)
Mar 2006
-
-$4700.00(-50.0%)
-$101.80K(-28.7%)
Dec 2005
-
-$9400.00(-77.6%)
-$142.80K(+3.9%)
Sep 2005
-$91.70K(+532.4%)
-$42.00K(-8.1%)
-$137.50K(+44.0%)
Jun 2005
-
-$45.70K(0.0%)
-$95.50K(+91.8%)
Mar 2005
-
-$45.70K(+1014.6%)
-$49.80K(+1114.6%)
Dec 2004
-
-$4100.00
-$4100.00
Sep 2004
-$14.50K
-
-

FAQ

  • What is Anavex Life Sciences annual operating income?
  • What is the all time high annual operating profit for Anavex Life Sciences?
  • What is Anavex Life Sciences annual operating profit year-on-year change?
  • What is Anavex Life Sciences quarterly operating income?
  • What is the all time high quarterly operating profit for Anavex Life Sciences?
  • What is Anavex Life Sciences quarterly operating profit year-on-year change?
  • What is Anavex Life Sciences TTM operating income?
  • What is the all time high TTM operating profit for Anavex Life Sciences?
  • What is Anavex Life Sciences TTM operating profit year-on-year change?

What is Anavex Life Sciences annual operating income?

The current annual operating profit of AVXL is -$52.80M

What is the all time high annual operating profit for Anavex Life Sciences?

Anavex Life Sciences all-time high annual operating income is -$14.50K

What is Anavex Life Sciences annual operating profit year-on-year change?

Over the past year, AVXL annual operating income has changed by +$2.93M (+5.26%)

What is Anavex Life Sciences quarterly operating income?

The current quarterly operating profit of AVXL is -$12.42M

What is the all time high quarterly operating profit for Anavex Life Sciences?

Anavex Life Sciences all-time high quarterly operating income is -$4100.00

What is Anavex Life Sciences quarterly operating profit year-on-year change?

Over the past year, AVXL quarterly operating income has changed by -$265.00K (-2.18%)

What is Anavex Life Sciences TTM operating income?

The current TTM operating profit of AVXL is -$54.99M

What is the all time high TTM operating profit for Anavex Life Sciences?

Anavex Life Sciences all-time high TTM operating income is -$4100.00

What is Anavex Life Sciences TTM operating profit year-on-year change?

Over the past year, AVXL TTM operating income has changed by -$5.27M (-10.61%)
On this page